NPR logo

FDA Approves ImClone Cancer Drug

  • Download
  • <iframe src="https://www.npr.org/player/embed/1673112/1673113" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
FDA Approves ImClone Cancer Drug

Science

FDA Approves ImClone Cancer Drug

FDA Approves ImClone Cancer Drug

  • Download
  • <iframe src="https://www.npr.org/player/embed/1673112/1673113" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

The Food and Drug Administration approves Erbitux, a colon cancer drug made by ImClone. The drug is at the center of the insider-trading trial of Martha Stewart. Stewart's sale of shares in the company occurred shortly after ImClone received a letter from the FDA saying Erbitux would not be approved. NPR's Snigdha Prakash reports.

We no longer support commenting on NPR.org stories, but you can find us every day on Facebook, Twitter, email, and many other platforms. Learn more or contact us.